Despite all this, incidences of infections resistant to multidrug therapies and last-resort treatments have significantly increased in the EU in recent years.
Sellele vaatamata on multiresistentsete või viimase valiku ravile resistentsete nakkusjuhtude arv viimastel aastatel ELis oluliselt suurenenud.